학술논문

Radium-223: down to the bone, and less is more
Document Type
Report
Source
Oncology. April, 2012, Vol. 26 Issue 4, 342
Subject
Prostate cancer -- Care and treatment -- Development and progression
Bone cancer -- Risk factors -- Care and treatment
Metastasis -- Care and treatment
Radiopharmaceuticals -- Usage -- Health aspects
Drug therapy, Combination -- Usage -- Health aspects
Health
Language
English
ISSN
0890-9091
Abstract
In this issue of ONCOLOGY, Cheetham and Petrylak deliver an in-depth review of radium-223 ([sup.223]Ra, Alpharadin) for the treatment of bone metastases in patients with castrate-resistant prostate cancer. This article [...]